EAM
ALNY icon

Eagle Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Eagle Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$85.9M Buy
309,589
+63,385
+26% +$16.5M 0.44% 84
2024
Q2 		$59.9M Sell
246,204
-12,044
-5% -$1.9M 0.32% 111
2024
Q1 		$39.6M Sell
258,248
-4,617
-2% -$770K 0.2% 142
2023
Q4 		$50.3M Buy
262,865
+185
+0.1% +$31.5K 0.27% 125
2023
Q3 		$46.5M Buy
262,680
+3,725
+1% +$711K 0.28% 125
2023
Q2 		$49.2M Sell
258,955
-4,493
-2% -$891K 0.27% 123
2023
Q1 		$52.8M Sell
263,448
-225
-0.1% -$47.3K 0.31% 111
2022
Q4 		$61.6M Buy
263,673
+153
+0.1% +$32.6K 0.38% 102
2022
Q3 		$52.7M Buy
263,520
+2,217
+0.8% +$423K 0.34% 104
2022
Q2 		$38.1M Buy
261,303
+5,366
+2% +$761K 0.24% 138
2022
Q1 		$41.8M Buy
255,937
+607
+0.2% +$92.5K 0.21% 144
2021
Q4 		$43.7M Buy
255,330
+1,549
+0.6% +$288K 0.19% 156
2021
Q3 		$47.9M Sell
253,781
-2,128
-0.8% -$399K 0.22% 158
2021
Q2 		$43.4M Sell
255,909
-249
-0.1% -$36.5K 0.19% 166
2021
Q1 		$36.3M Buy
256,158
+14,078
+6% +$2.12M 0.16% 190
2020
Q4 		$31.5M Sell
242,080
-19,794
-8% -$2.64M 0.18% 182
2020
Q3 		$38M Buy
261,874
+54
+0% +$7.67K 0.2% 175
2020
Q2 		$38.7M Buy
+261,820
New +$35.3M 0.22% 157
2013
Q4 		– Sell
-96,415
Closed -$6.18M – 616
2013
Q3 		$6.18M Buy
+96,415
New +$4.81M 0.03% 448

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Eagle Asset Management's ALNY Position: Q3 2024 in Review

Eagle Asset Management increased its Alnylam Pharmaceuticals (ALNY) stake by 26% in Q3 2024, buying an estimated $16.5M and bringing the position to 309,589 shares worth $85.9M. The position accounts for 0.44% of the portfolio, ranked #84.

Eagle Asset Management first reported a position in ALNY in Q3 2013 and has held it in 19 quarters since. 567 funds tracked by Wall St. Rank hold ALNY as of Q3 2024.

  • Eagle Asset Management held 309,589 shares of Alnylam Pharmaceuticals worth $85.9M as of Q3 2024.
  • Eagle Asset Management bought 63,385 Alnylam Pharmaceuticals shares in Q3 2024, an estimated $16.5M.
  • Alnylam Pharmaceuticals made up 0.44% of Eagle Asset Management's portfolio in Q3 2024, its #84 holding.
  • Eagle Asset Management first reported a position in Alnylam Pharmaceuticals in Q3 2013 and has held it in 19 quarters since.
  • 567 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.